The ICMAB endorses the EU Manifesto for Open Access of COVID-19 research results
The European Commission has launched a Manifesto to maximise the accessibility of research results in the fight against COVID-19. The manifesto provides guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment.
The ICMAB has signed this Manifesto, whose indications are in line with the Open Science policies that our Institute follows and supports. As a consequence, our published papers and research data, will be made public without delay, by publishing them in the DIGITAL CSIC institutional repository and other relevant platforms.
Endorse the Manifesto
The manifesto seeks the voluntary support and endorsement from public and private stakeholders benefitting from EU funding, other research funders and prominent individuals and institutions. Endorsing the manifesto does not entail legal implications for signed grants. This initiative is in line with several international actions such as the COVID-19 resolution adopted by the World Health Assembly on 19 May and the Solidarity call for Action by the World Health Organisation.
Many research institutions from around Europe have already endorsed the Manifesto. You can see the full list here.
Maximising the accessibility of research results in the fight against COVID-19
- Considering the unprecedented, extraordinary challenges posed by the outbreak of the COVID-19 pandemic;
- Encouraged by the broad public recognition of the important role of research and innovation in containing the COVID-19 pandemic;
- Recalling the World Health Assembly resolution on COVID-191 and EU Strategy for COVID-19 vaccines2 supporting the voluntary pooling and licensing of intellectual property related to COVID-19 therapeutics and vaccines, to promote equitable global access as well as a fair return on investments;
- Fully aware of our responsibility as researchers and innovators to find innovative solutions;
- Bearing in mind the urgent need to valorise research results for the benefit of all;
We agree and endorse the principles below when dealing with research results stemming from EU funded research grants related to COVID-19 on prevention (including vaccines), testing and treatment:
- Make the generated results, whether tangible or intangible, public and accessible without delay, for instance on the Horizon Results Platform, on an existing IP sharing platform, or through an existing patent pool.
- Make scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation. In particular, make COVID-19 research data available through the European COVID-19 Data Platform.
- Where possible, grant for a limited time3, non-exclusive royalty free licences on the intellectual property resulting from EU-funded research. These non-exclusive royalty free licenses shall be given in exchange for the licensees’ commitment to rapidly and broadly distribute the resulting products and services under fair and reasonable conditions to prevent, diagnose, treat and contain COVID-19.
Share the Manifesto with the hashtags #ResearchImpactEU #EU #InvestEUResearch #UnitedAgainstCoronaVirus #H2020 #HorizonEU
- Hits: 340